SCIE期刊CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 2024/2025影响因子:2.496 (CANCER BIOTHER RADIO) (1084-9785). (RADIOLOGY, NU

显示全部楼层 · 发表于 2025-3-23 10:32:57

Submitted on: 24 July 2003. Revised on: 15 September 2003. Accepted on: 15 October 2003. ___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

显示全部楼层 · 发表于 2025-3-23 17:10:51

Submitted on: 29 October 2011. Revised on: 31 December 2011. Accepted on: 19 February 2012. ___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

显示全部楼层 · 发表于 2025-3-23 19:15:12

显示全部楼层 · 发表于 2025-3-24 00:22:15

显示全部楼层 · 发表于 2025-3-24 04:45:39

显示全部楼层 · 发表于 2025-3-24 09:37:26

显示全部楼层 · 发表于 2025-3-24 12:21:34

Submitted on: 25 September 2000. Revised on: 14 November 2000. Accepted on: 18 December 2000. ___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

显示全部楼层 · 发表于 2025-3-24 16:56:55

Submitted on: 06 April 2024. Revised on: 09 July 2024. Accepted on: 07 September 2024. ___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

显示全部楼层 · 发表于 2025-3-24 20:03:35

显示全部楼层 · 发表于 2025-3-25 00:43:44

Submitted on: 14 July 1999. Revised on: 25 August 1999. Accepted on: 15 September 1999. ___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 11:04
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

SCIE期刊CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 2024/2025影响因子:2.496 (CANCER BIOTHER RADIO) (1084-9785). (RADIOLOGY, NU

浏览过的版块